BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12520580)

  • 1. The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996-2001.
    Sauven P; Bishop H; Patnick J; Walton J; Wheeler E; Lawrence G; ;
    Br J Surg; 2003 Jan; 90(1):82-7. PubMed ID: 12520580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The West Midlands breast cancer screening status algorithm - methodology and use as an audit tool.
    Lawrence G; Kearins O; O'Sullivan E; Tappenden N; Wallis M; Walton J
    J Med Screen; 2005; 12(4):179-84. PubMed ID: 16417694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening Programme.
    Gathani T; Bull D; Green J; Reeves G; Beral V;
    Breast Cancer Res; 2005; 7(6):R1090-6. PubMed ID: 16457689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a national external quality assessment scheme for breast pathology in the UK.
    Ellis IO; Coleman D; Wells C; Kodikara S; Paish EM; Moss S; Al-Sam S; Anderson N; Bobrow L; Buley I; Connolly CE; Dallimore NS; Hales S; Hanby A; Humphreys S; Knox F; Lowe J; Macartney J; Nash R; Parham D; Patnick J; Pinder SE; Quinn CM; Robertson AJ; Shrimankar J; Walker RA; Winder R
    J Clin Pathol; 2006 Feb; 59(2):138-45. PubMed ID: 16443727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.
    Rakha EA; Bennett RL; Coleman D; Pinder SE; Ellis IO;
    J Clin Pathol; 2017 Jan; 70(1):51-57. PubMed ID: 27406051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A one-year audit of 255 operable breast cancers.
    McCarthy DO; Blamey RW; Robertson JF; Mitchell AK
    Eur J Surg Oncol; 1997 Oct; 23(5):399-402. PubMed ID: 9393566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance in breast cancer screening cytology: a review of the literature and a report on the U.K. national cytology scheme.
    Wells CA
    Eur J Cancer; 1995; 31A(2):273-80. PubMed ID: 7718337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United Kingdom national audit of breast fine needle aspiration cytology in 1990-91--organization and level of activity.
    Hunt CM; Wilson S; Pinder SE; Elston CW; Ellis IO
    Cytopathology; 1996 Oct; 7(5):316-25. PubMed ID: 8911755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning for quality in the NHS breast screening programme.
    Gray JA
    Qual Health Care; 1992 Jun; 1(2):119-23. PubMed ID: 10136841
    [No Abstract]   [Full Text] [Related]  

  • 11. The United Kingdom national breast screening programme: implications for pathology departments.
    Elston CW
    Med Lab Sci; 1989 Jul; 46(3):223-9. PubMed ID: 2691798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions.
    El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
    Eur J Cancer; 2008 Nov; 44(17):2580-6. PubMed ID: 18632261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NHSBSP type 1 interval cancers: a scientifically valid grouping?
    Porter GJ; Evans AJ; Burrell HC; Lee AH; Chakrabarti J
    Clin Radiol; 2007 Mar; 62(3):262-7. PubMed ID: 17293220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the clinical efficacy of minimally invasive procedures for breast cancer screening at a teaching hospital.
    Verenhitach BD; Elias S; Patrocínio AC; Nazário AC; Waizberg A
    J Clin Pathol; 2011 Oct; 64(10):858-61. PubMed ID: 21666140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast screening: PERFORMS identifies key mammographic training needs.
    Scott HJ; Gale AG
    Br J Radiol; 2006 Dec; 79 Spec No 2():S127-33. PubMed ID: 17209118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine breast screening for women aged 65-69: results from evaluation of the demonstration sites.
    Moss SM; Brown J; Garvican L; Coleman DA; Johns LE; Blanks RG; Rubin G; Oswald J; Page A; Evans A; Gamble P; Wilson R; Lee L; Liston J; Sturdy L; Sutton G; Wardman G; Patnick J; Winder R
    Br J Cancer; 2001 Nov; 85(9):1289-94. PubMed ID: 11720462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Health Service Breast Screening Programme in the Trent region--are we meeting the targets?
    Holland PA; Dadra S; Holt S
    Eur J Surg Oncol; 1998 Apr; 24(2):99-103. PubMed ID: 9591023
    [No Abstract]   [Full Text] [Related]  

  • 18. Coverage in the National Health Service Breast Screening Programme, 1996-2005: correcting for the first invitation of women between 50 and 52 years.
    Bennett RL; Blanks RG; Moss SM
    J Public Health (Oxf); 2008 Jun; 30(2):167-70. PubMed ID: 18339650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should a standard be defined for the Positive Predictive Value (PPV) of recall in the UK NHS Breast Screening Programme?
    Bennett RL; Blanks RG
    Breast; 2007 Feb; 16(1):55-9. PubMed ID: 16904891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Breast Screening Programme: the first 5,000 women screened in Northern Ireland.
    O'Doherty AJ; Crothers JG; Majury CW
    Ulster Med J; 1991 Oct; 60(2):150-3. PubMed ID: 1785147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.